Skip to main content
BELLUSCURA PLC logo

BELLUSCURA PLC — Investor Relations & Filings

Ticker · BELL ISIN · GB00BD3B8Z11 LEI · 213800BRJQZE56XBPW94 IL Manufacturing
Open in API
Filings indexed 240 across all filing types
Latest filing 2022-04-01 Report Publication Anno…
Country GB United Kingdom
Listing IL BELL

About BELLUSCURA PLC

https://belluscura.com/

Belluscura PLC is a medical device company specializing in the development and commercialization of advanced oxygen enrichment technologies. The company's primary focus is on manufacturing lightweight, portable oxygen concentrators (POCs) designed to improve the quality of life for individuals requiring supplemental oxygen therapy. Its product portfolio is headlined by the FDA-cleared X-PLOR® and the DISCOV-R™ models. These devices utilize proprietary, patented technologies such as ModulAir™ and an Airgonomical™ design to deliver high oxygen output in a compact form factor, offering an alternative to traditional, cumbersome oxygen tanks and promoting user mobility and independence.

Recent filings

Filing Released Lang Actions
Notice of AGM and Annual Report 2021
Report Publication Announcement Classification · 99% confidence The document is a short announcement (3283 characters) released via RNS (RNS Number : 8365G) on April 1, 2022. The title explicitly states "Notice of AGM and Annual Report 2021". The text confirms that the 'Notice of Annual General Meeting ("Notice") is being posted shareholders today' and that the 'Annual Report and Accounts for the year ended 31 December 2021 is being posted along with the Notice'. According to Rule 2 (The 'MENU VS MEAL' Rule), when a document announces the publication or posting of a report (like the Annual Report or AGM Notice) rather than containing the full content of those reports, it should be classified as a Report Publication Announcement (RPA). Since this filing serves to announce the release of both the AGM materials and the Annual Report, RPA is the most appropriate classification.
2022-04-01 English
Manufacturing Agreement
Regulatory Filings Classification · 98% confidence The document begins with 'RNS Number' and is dated March 30, 2022. It explicitly states it contains 'INSIDE INFORMATION AS STIPULATED UNDER THE UK VERSION OF THE MARKET ABUSE REGULATION' and is published via a 'REGULATORY INFORMATION SERVICE'. The content details a significant business event: entering a 'transformational Global Manufacturing Agreement'. This structure—a brief announcement of material, non-public information released through an official news service (RNS) under regulatory requirements—is characteristic of a general regulatory announcement rather than a full financial report (like 10-K or IR) or a specific corporate action filing (like DIV or CAP). Since it is a regulatory announcement that doesn't fit the highly specific categories like DIRS, MANG, or DIV, the most appropriate fallback is Regulatory Filings (RNS). The document length is moderate (5806 chars), but its primary function is dissemination via RNS.
2022-03-30 English
Final Results
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Unaudited Preliminary Results for the year ended 31 December 2021' and contains detailed financial highlights, operational highlights, a Chairman's statement, a Chief Executive's review, and a financial review including income statements and balance sheet data. It is a comprehensive report of financial performance for a specific period, fitting the definition of an Interim/Quarterly Report (IR) or Preliminary Results, which are classified under the IR category in this schema. FY 2021
2022-02-22 English
Second Price Monitoring Extn
Regulatory Filings Classification · 98% confidence The document explicitly starts with 'RNS Number' and mentions 'RNS, the news service of the London Stock Exchange' multiple times. The content describes a 'Second Price Monitoring Extension' related to trading activity, which is a specific type of market announcement. Since this is a general regulatory announcement disseminated via the RNS system and does not fit into the more specific categories like Director's Dealing (DIRS), Dividend Notice (DIV), or Capital Change (CAP), it falls best under the general Regulatory Filings category (RNS). The document length is short (1931 chars) and it is a direct announcement, not an announcement *about* a major report.
2022-01-27 English
Price Monitoring Extension
Regulatory Filings Classification · 99% confidence The document explicitly starts with 'RNS Number' and contains information about a 'Price Monitoring Extension' related to trading on the London Stock Exchange. It concludes by stating that the information is provided by RNS, the news service of the London Stock Exchange, which is approved by the Financial Conduct Authority (FCA) as a Primary Information Provider. This structure and content strongly indicate a general regulatory announcement disseminated via the RNS system, which aligns best with the 'Regulatory Filings' category, especially since it is not a specific financial report (like 10-K, ER, or IR) or a specific corporate action announcement (like DIV or DIRS). Given the short length and nature as a market operational update disseminated via RNS, the fallback category 'RNS' is the most appropriate classification.
2022-01-27 English
Trading Update and Notice of Preliminary Results
Regulatory Filings Classification · 98% confidence The document is identified by the 'RNS Number' header and explicitly states it is provided by 'RNS, the news service of the London Stock Exchange'. The content is a 'Trading Update and Notice of Preliminary Results' for the year ended 31 December 2021, providing key operational highlights (sales figures, inventory, cash balances) and announcing that the full 'preliminary results' will be released in mid-February. Since this is a short announcement (5019 chars) that provides an update and explicitly gives notice about the future release of the full financial report, it fits the definition of a Report Publication Announcement (RPA) or, given the RNS source and general nature, a Regulatory Filing (RNS). Because it contains specific financial updates and a notice about the upcoming full results, RPA is a strong candidate, but RNS is the most general fit for LSE regulatory news releases that aren't one of the highly specific types (like 10-K, ER, or DIV). Given the content is a trading update and a notice of results, it is a regulatory announcement. Since it is not the full Earnings Release (ER) or the full Annual Report (10-K), and it explicitly announces the publication of results, RPA is highly appropriate, but RNS covers all general regulatory announcements from this source. I will classify it as RNS as it is a standard LSE regulatory news service release.
2022-01-24 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.